Bone Biologics (BBLG) Earnings Analysis
Bone Biologics (BBLG) next reports earnings on 2026-08-13, consensus EPS -0.39 USD. Last quarter (2026-05-14) it beat with EPS -0.43 USD vs -0.43 USD est (0%). It has beaten estimates in 5/8 recent quarters (63%). Trailing P/E -0.40.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does BBLG next report earnings?
| Next earnings date | 2026-08-13 |
|---|---|
| Consensus EPS estimate | -0.39 USD |
| Revenue estimate | n/a |
BBLG earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-14 | -0.43 USD | -0.43 USD | 0% | Beat |
| 2026-03-02 | -0.14 USD | -0.34 USD | +58.8% | Beat |
| 2025-11-14 | -0.37 USD | -1.23 USD | +69.9% | Beat |
| 2025-08-14 | -1.33 USD | -0.58 USD | -129.3% | Miss |
| 2025-05-12 | -1.92 USD | -0.48 USD | -300% | Miss |
| 2025-03-05 | -0.61 USD | -0.65 USD | +6.2% | Beat |
| 2024-11-14 | -14.22 USD | -3.6 USD | -295% | Miss |
| 2024-08-09 | -4.02 USD | -8.34 USD | +51.8% | Beat |
Beat rate: 5/8 (63%) over reported quarters with consensus data.
BBLG valuation and analyst view
| Trailing P/E | -0.40 |
|---|---|
| Trailing EPS | -1.59191 USD |
| Price / book | 0.42 |
| Dividend yield | 0.00% |
| Market cap | 0.00B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Bone Biologics (BBLG)'s next earnings date?
Bone Biologics is next scheduled to report on 2026-08-13, with a consensus EPS estimate of -0.39 USD.
Did BBLG beat earnings last quarter?
In its 2026-05-14 report, BBLG posted EPS of -0.43 USD versus a -0.43 USD estimate — a beat of 0%.
What is BBLG's earnings track record?
Over the last 8 reported quarters with consensus data, BBLG beat estimates 5 times (63%).
What is BBLG's current P/E ratio and EPS?
BBLG trades at a trailing P/E of -0.40 on trailing EPS of -1.591907021824137 USD.
What do analysts rate BBLG?
BBLG has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.